Author:
Hocher Berthold,Adamski Jerzy
Publisher
Springer Science and Business Media LLC
Reference193 articles.
1. Zhang, Q. L. & Rothenbacher, D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 8, 117 (2008).
2. Jha, V., Wang, A. Y. & Wang, H. The impact of CKD identification in large countries: the burden of illness. Nephrol. Dial. Transplant. 27 (Suppl. 3), iii32–iii38 (2012).
3. Stevens, P. E., Levin, A. & Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann. Intern. Med. 158, 825–830 (2013).
4. KDIGO. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. Suppl. 3, 4 (2013). Guidelines for the diagnosis and treatment of CKD that are used wordwide in clinical practice and research.
5. Ferguson, T. W., Komenda, P. & Tangri, N. Cystatin C as a biomarker for estimating glomerular filtration rate. Curr. Opin. Nephrol. Hypertens. 24, 295–300 (2015).
Cited by
260 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献